Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates

Lucid Diagnostics reported an earnings surprise of -42.86% and a revenue surprise of +15.69% for the quarter ended December 2025. The large EPS miss alongside a material top-line beat is a mixed signal that raises near-term uncertainty for LUCD shares and is likely to move the stock as investors focus on margins, cost controls and any management guidance.

Analysis

Lucid Diagnostics reported an earnings surprise of -42.86% and a revenue surprise of +15.69% for the quarter ended December 2025. The large EPS miss alongside a material top-line beat is a mixed signal that raises near-term uncertainty for LUCD shares and is likely to move the stock as investors focus on margins, cost controls and any management guidance.